Leelamine - CAS 1446-61-3
Catalog number:
1446-61-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H31N
Molecular Weight:
285.5
COA:
Inquire
Targets:
Cannabinoid Receptor
Description:
Leelamine, a diterpene molecule, has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Leelamine is also a PDK(pyruvate dehydrogenase kinase inhibitor).
Publictions citing BOC Sciences Products
  • >> More
Related CAS:
16496-99-4 (Leelamine hydrochloride salt); 1446-61-3 (Leelamine)
Appearance:
Solid powder
Synonyms:
[(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine; dehydroabietylamine; DEHYDROABIETYLAMINE; (+)-Dehydroabietylamine; Dehydroabiethylamine; 16496-99-4 Leelamine (hydrochloride)
Solubility:
Soluble in DMSO
Storage:
Desiccate at -20°C
MSDS:
Inquire
Boiling Point:
250 °C | Condition: Press: 12 Torr
Melting Point:
44.50 °C
Density:
1.5460 g/cm3
InChIKey:
JVVXZOOGOGPDRZ-SLFFLAALSA-N
InChI:
1S/C20H31N/c1-14(2)15-6-8-17-16(12-15)7-9-18-19(3,13-21)10-5-11-20(17,18)4/h6,8,12,14,18H,5,7,9-11,13,21H2,1-4H3/t18-,19-,20+/m0/s1
Canonical SMILES:
CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)CN)C
1.Synthesis and applications of secondary amine derivatives of (+)-dehydroabietylamine in chiral molecular recognition.
Laaksonen T1, Heikkinen S, Wähälä K. Org Biomol Chem. 2015 Nov 14;13(42):10548-55. doi: 10.1039/c5ob01667c. Epub 2015 Sep 4.
(+)-Dehydroabietylamine (1a), the novel derivatives (2a-6a) and their NTf2 salts (1b-6b) were tested as chiral NMR solvating agents for the resolution of enantiomers of the model compound Mosher's acid (7) and its n-Bu4N salt (8). Best enantiomeric discrimination of 7 was obtained using bisdehydroabietylamino-N(1),N(2)-ethane-1,2-diamine (6a), and of 8 using N-(dehydroabietyl)-2-(dehydroabietylamino)ethanaminium bis((trifluoromethyl)-sulfonyl)-amide (6b). For the maximal resolution of enantiomers of 8, 1.0 eq. of 6b were needed. However, 0.5 eq. of 6a sufficed for the maximal resolution of enantiomers of 7. Enantiomeric excess studies were successfully conducted using 6a and 6b. The capability of 6a and 6b to recognize the enantiomers of various α-substituted carboxylic acids and their n-Bu4N salts were examined. Best resolutions were observed for aliphatic and aromatic carboxylic acids bearing an electronegative α-substituent. Now the ee studies on such non-aromatic carboxylic acids are also feasible.
2.(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
Ling T1, Tran M1, González MA2, Gautam LN1, Connelly M1, Wood RK3, Fatima I3, Miranda-Carboni G3, Rivas F4. Eur J Med Chem. 2015 Sep 18;102:9-13. doi: 10.1016/j.ejmech.2015.07.034. Epub 2015 Jul 23.
Breast cancer remains the leading cause of cancer-related death among women. The invasive triple-negative subtype is unresponsive to estrogen therapy, and few effective treatments are available. In search of new chemical scaffolds to target this disease, we conducted a phenotypic screen against the human breast carcinoma cell lines MDA-MB-231, MA11, and MCF-7 using terrestrial natural products. Natural products that preferentially inhibited proliferation of triple-negative MDA-MB-231 cells over estrogen receptor-positive cells were further studied; herein we focused on the abietanes. The activity of the abietane carnosol prompted us to generate a focus library from the readily available (+)-dehydroabietylamine. The lead compound 61 displayed a promising EC50 of 9.0 μM against MDA-MB-231 and our mechanistic studies indicate it induced apoptosis, which was associated with activation of caspase-9 and -3 and the cleavage of PARP. Here we describe our current progress towards this promising therapeutic candidate.
3.Anti-herpetic and anti-dengue activity of abietane ferruginol analogues synthesized from (+)-dehydroabietylamine.
Roa-Linares VC1, Brand YM1, Agudelo-Gomez LS2, Tangarife-Castaño V2, Betancur-Galvis LA1, Gallego-Gomez JC3, González MA4. Eur J Med Chem. 2016 Jan 27;108:79-88. doi: 10.1016/j.ejmech.2015.11.009. Epub 2015 Nov 11.
The abietane-type diterpenoid (+)-ferruginol (1), a bioactive compound isolated from several plants, has attracted much attention as consequence of its pharmacological properties, which includes antibacterial, antifungal, antimicrobial, cardioprotective, anti-oxidative, anti-plasmodial, leishmanicidal, anti-ulcerogenic, anti-inflammatory and antitumor actions. In this study, we report on the antiviral evaluation of ferruginol (1) and several analogues synthesized from commercial (+)-dehydroabietylamine. Thus, the activity against Human Herpesvirus type 1, Human Herpesvirus type 2 and Dengue Virus type 2, was studied. Two ferruginol analogues showed high antiviral selectivity index and reduced viral plaque-size in post-infection stages against both Herpes and Dengue viruses. A promising lead, compound 8, was ten-fold more potent (EC50 = 1.4 μM) than the control ribavirin against Dengue Virus type 2. Our findings suggest that the 12-hydroxyabieta-8,11,13-triene skeleton, which is characteristic of the diterpenoid ferruginol (1), is an interesting molecular scaffold for development of novel antivirals.
4.A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activity.
Sadashiva MP1, Gowda R2, Wu X3, Inamdar GS2, Kuzu OF2, Rangappa KS4, Robertson GP2, Gowda DC5. Exp Parasitol. 2015 Aug;155:68-73. doi: 10.1016/j.exppara.2015.05.002. Epub 2015 May 14.
Malaria caused by the Plasmodium parasites continues to be an enormous global health problem owing to wide spread drug resistance of parasites to many of the available antimalarial drugs. Therefore, development of new classes of antimalarial agents is essential to effectively treat malaria. In this study, the efficacy of naturally occurring diterpenoids, dehydroabietylamine and abietic acid, and their synthetic derivatives was assessed for antimalarial activity. Dehydroabietylamine and its N-trifluoroacetyl, N-tribromoacetyl, N-benzoyl, and N-benzyl derivatives showed excellent activity against P. falciparum parasites with IC50 values of 0.36 to 2.6 µM. Interestingly, N-dehydroabietylbenzamide showed potent antimalarial activity (IC50 0.36), and negligible cytotoxicity (IC50 >100 µM) to mammalian cells; thus, this compound can be an important antimalarial drug. In contrast, abietic acid was only marginally effective, exhibiting an IC50 value of ~82 µM.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Cannabinoid Receptor Products


CAS 686347-12-6 Otenabant HCl

Otenabant HCl
(CAS: 686347-12-6)

Otenabant HCl is a selective and high affinity antagonist of CB1 with Ki value of 0.7 nM.

AM-1220
(CAS: 134959-64-1)

AM-1220 is a selective cannabinoid receptor CB1 agonist , with about 19x selectivity for CB1 over the related CB2 receptor originated by Sterling Winthrop. In O...

CAS 686344-29-6 Otenabant (CP-945,598)

Otenabant (CP-945,598)
(CAS: 686344-29-6)

Otenabant, also known as CP-945,598, is a drug which acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesi...

CAS 1048973-47-2 MDA 19

MDA 19
(CAS: 1048973-47-2)

MDA 19, a benzohydrazide derivative, has been found to be a CB2 receptor agonist and could be useful in reducting the Attenuates tactile allodynia of rats. IC50...

CAS 701977-09-5 Taranabant

Taranabant
(CAS: 701977-09-5)

Taranabant is a cannabinoid 1 receptor inverse agonist ( IC50 =0.3 nM).

AM 1714
(CAS: 335371-37-4)

AM 1714, a synthetic cannabimimetic indole derivative, is a potent and selective agonist for the cannabinoid receptor.

CAS 158681-13-1 Rimonabant Hydrochloride

Rimonabant Hydrochloride
(CAS: 158681-13-1)

Rimonabant Hydrochloride, used as a tool to investigate CB receptor properties, it is a selective antagonist of cannabinoid CB1 receptor (Ki = 1.98 nM) and inve...

CAS 868273-06-7 ORG-27569

ORG-27569
(CAS: 868273-06-7)

Org 27569 is an allosteric modulator of cannabinoid CB1 receptor, induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased ...

CAS 406205-74-1 BAY 59-3074

BAY 59-3074
(CAS: 406205-74-1)

Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist(Ki values are 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively).

CB1-IN-1
(CAS: 1429239-98-4)

CB1-IN-1 is an antagonist of cannabinoid receptor type 1 (CB1R) located in the peripheral nervous system, which may be significant for pain modulation.

CAS 212188-60-8 BAY 38-7271

BAY 38-7271
(CAS: 212188-60-8)

BAY 38-7271, also called as KN 38-7271, is a cannabinoid receptor agonist with analgesic and neuroprotective effects. The doses of BAY 38-7271 in animals needed...

CAS 861151-12-4 Rosonabant

Rosonabant
(CAS: 861151-12-4)

Rosonabant is a CB1 receptor antagonist/inverse agonist originated by Esteve. It is an appetite suppressant for the treatment of obesity. But development of the...

CAS 432047-72-8 CB-13

CB-13
(CAS: 432047-72-8)

CB-13 is a dual agonist of the CB1 (IC50 = 15 nM) and CB2 (IC50 = 98 nM) receptors, displays antihyperalgesic activity in a rat model of neuropathic pain with n...

CAS 180002-83-9 L-768242

L-768242
(CAS: 180002-83-9)

L-768242, an indole derivative, has been found to be a CB2 receptor agonist and was once studied to exhibit anti-nociceptive and antihyperalgesic activities in ...

CAS 168273-06-1 Rimonabant

Rimonabant
(CAS: 168273-06-1)

Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.

CAS 220556-69-4 ACEA

ACEA
(CAS: 220556-69-4)

ACEA is a selective cannabinoid receptor 1 (CB1R) agonist (Ki = 1.4 nM) with much higher affinity over CB2R. CB1 receptors are mainly expressed in the central a...

CAS 131543-23-2 WIN 55212-2 mesylate

WIN 55212-2 mesylate
(CAS: 131543-23-2)

The mesylate salt form of WIN 55212-2, an aminoalkylindole derivative, is a CB receptor agonist and could be effective against some inflammatory reponse. IC50: ...

Levonantradol hydrochloride
(CAS: 70222-86-5)

Levonantrado is a synthetic cannabinoid analog of dronabinol developed by Pfizer in the 1980s. Levonantrado is around 30x more potent than THC, and exhibits ant...

CAS 183232-66-8 AM251

AM251
(CAS: 183232-66-8)

AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 ...

CAS 335160-66-2 AM 1248

AM 1248
(CAS: 335160-66-2)

AM1248 is an adamantoylindole derivative acts as a moderately potent agonist for both the cannabinoid receptors CB1 and CB2.

Chemical Structure

CAS 1446-61-3 Leelamine

Quick Inquiry

Verification code

Featured Items